Pharmacists in Imlay City, MI Accepting Medicare

10 Pharmacists found. Showing 1 - 10

Dr. Craig Charles Heimbach, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 557 N Cedar St, Imlay City, MI 48444 Phone: 810-724-0576    Fax: 810-724-3486

Mr. Gaurang M Patel, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 557 N Cedar St, Imlay City, MI 48444 Phone: 810-724-0576

Rajpal Kalsi Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2070 S Cedar St, Imlay City, MI 48444 Phone: 810-724-7692    Fax: 810-724-6064

Nagarjuna Gunturu Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 557 N Cedar St, Imlay City, MI 48444 Phone: 810-724-0576    Fax: 810-724-3486

Carolyn Eckhout Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6672 Newark Rd, Imlay City, MI 48444 Phone: 810-724-0591    Fax: 810-724-0272

Dr. Joleana Marie Brandt Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1821 S Cedar St, Imlay City, MI 48444 Phone: 801-721-3262

Rebecca Mcinerney-logan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 557 N Cedar St, Imlay City, MI 48444 Phone: 810-724-0576

Mariam Tawadrous Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 557 N Cedar St, Imlay City, MI 48444 Phone: 810-724-0576

Donald Kubik Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2040 S Cedar St, Imlay City, MI 48444 Phone: 810-724-7692

Hazar Aflak Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 1821 S Cedar St, Imlay City, MI 48444 Phone: 810-721-3262    Fax: 810-721-3263

News Archive

Drugs against protective action of bacteria's antitoxin molecules

Bacteria often attack with toxins designed to hijack or even kill host cells. To avoid self-destruction, bacteria have ways of protecting themselves from their own toxins.

Afatinib benefits lung cancer patients whose cancer progressed after treatment with EGFR inhibitors

Lung cancer patients who have already been treated with the EGFR inhibitors erlotinib or gefitinib seem to gain further benefits in terms of progression-free survival and tumor shrinkage when treated with the new drug afatinib, the results of a Phase IIb/III trial show.

Emergex completes toxicology testing on gold nanoparticle carrier system for vaccine platform

Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces the successful completion of preclinical toxicology testing on the gold nanoparticle carrier system that forms the fundamental basis for Emergex's entire infectious disease vaccine platform.

Brains of both black and white people have been programmed by racist stereotyping

Scientists at the University of California, Los Angeles, carried out brain scans of black and white Americans, focusing on a part of the brain called the amygdala, the area that reacts to threat and novelty, and, because the region responds in different ways, exactly what goes on in that area was unclear.

GW researcher receives grant to examine link between liver fluke infection and bile duct cancer

Liver fluke infection is a major public health problem affecting more than 10 million people in Southeast Asia, particularly in Thailand and Laos. Infection has been strongly linked to cholangiocarcinoma, or bile duct cancer, an uncommon but aggressive form of cancer.

Read more Medical News

› Verified 2 days ago